The new Decipher genetic test may more accurately predict risk for metastasis following radical prostatectomy for prostate cancer, but will it improve outcomes?

Are declining PSA screening rates placing men at risk? Dr Chodak discusses the latest opinions for and against routine screening.

New findings from the UK show multimodal ovarian cancer screening to be highly effective in reducing mortality, but Dr Andrew Kaunitz urges clinicians to await guidelines for routine screening.

Past AACR president Dr Carlos Arteaga describes translational studies and emerging therapies that are transforming the clinical practice of breast cancer.

Awareness about antimicrobial resistance got a boost through recent campaigns such as Get Smart About Antibiotics Week.

Dr Paul Auwaerter shares good news from IDWeek 2015, including updates on anti-infectives--6 new weapons in the battle against resistant organisms.

Dr Leana Wen, city health commissioner for Baltimore, speaks with Medscape Editor-in-Chief Dr Eric Topol about her work as an emergency medicine physician and public health advocate.

Genetic testing is now ordered in the treatment of numerous cancer types. Is it useful? Is it even reliable? Dr John Marshall and world-class experts tackle key questions for practicing clinicians.

Eric Topol speaks with singer, songwriter, and oncologic scientist Nazneen Rahman on the importance of understanding the genetics of cancer.

Explorer of ancient DNA Svante Pääbo recounts to Eric Topol his journey from Egyptian mummies to sequencing the Neanderthal genome, and more.